SCM
AGIO icon

Sio Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Sio Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-35,000
Closed -$1.52M – 90
2020
Q4 		$1.52M Sell
35,000
-21,000
-38% -$830K 0.31% 72
2020
Q3 		$1.96M Buy
+56,000
New +$2.45M 0.39% 60

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sio Capital Management's AGIO Position: Q1 2021 in Review

Sio Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2021, closing a stake of 35,000 shares — an estimated $1.52M sold.

Sio Capital Management first reported a position in AGIO in Q3 2020 and held it in 2 quarters. The position peaked at $1.96M in Q3 2020. 175 funds tracked by Wall St. Rank hold AGIO as of Q1 2021.

  • Sio Capital Management reported no remaining Agios Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Sio Capital Management sold 35,000 Agios Pharmaceuticals shares in Q1 2021, an estimated $1.52M.
  • Sio Capital Management first reported a position in Agios Pharmaceuticals in Q3 2020 and held it in 2 quarters.
  • Sio Capital Management's Agios Pharmaceuticals position peaked at $1.96M in Q3 2020.
  • 175 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2021.

Based on Sio Capital Management's 13F filing for Q1 2021, filed 14 May 2021.